ICON2: Randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

M. K B Parmar, V. Torri, A. Bonaventura, C. Bonazzi, N. Colombo, J. F. Delaloye, S. Marsoni, C. Mangioni, J. Sandercock, C. Sessa, C. Williams, A. Tinazzi, M. Flann, K. Geiser, N. Scorpiglione

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'ICON2: Randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences